Literature DB >> 21062273

Paternal mosaicism of an STXBP1 mutation in OS.

H Saitsu1, H Hoshino, M Kato, K Nishiyama, I Okada, Y Yoneda, Y Tsurusaki, H Doi, N Miyake, M Kubota, K Hayasaka, N Matsumoto.   

Abstract

Ohtahara syndrome (OS) is one of the most severe and earliest forms of epilepsy. We have recently identified that the de novo mutations of STXBP1 are important causes for OS. Here we report a paternal somatic mosaicism of an STXBP1 mutation. The affected daughter had onset of spasms at 1 month of age, and interictal electroencephalogram showed suppression-burst pattern, leading to the diagnosis of OS. She had a heterozygous c.902+5G>A mutation of STXBP1, which affects donor splicing of exon 10, resulting in 138-bp insertion of intron 10 sequences in the transcript. The mutant transcript had a premature stop codon, and was degraded by nonsense-mediated mRNA decay in lymphoblastoid cells derived from the patient. High-resolution melting analysis of clinically unaffected parental DNAs suggested that the father was somatic mosaic for the mutation, which was also suggested by sequencing. Cloning of PCR products amplified with the paternal DNA samples extracted from blood, saliva, buccal cells, and nails suggested that 5.3%, 8.7%, 11.9%, and 16.9% of alleles harbored the mutation, respectively. This is a first report of somatic mosaicism of an STXBP1 mutation, which has implications in genetic counseling of OS.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062273     DOI: 10.1111/j.1399-0004.2010.01575.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  12 in total

1.  De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.

Authors:  Kazuyuki Nakamura; Hirofumi Kodera; Tenpei Akita; Masaaki Shiina; Mitsuhiro Kato; Hideki Hoshino; Hiroshi Terashima; Hitoshi Osaka; Shinichi Nakamura; Jun Tohyama; Tatsuro Kumada; Tomonori Furukawa; Satomi Iwata; Takashi Shiihara; Masaya Kubota; Satoko Miyatake; Eriko Koshimizu; Kiyomi Nishiyama; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Kiyoshi Hayasaka; Kazuhiro Ogata; Atsuo Fukuda; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Am J Hum Genet       Date:  2013-08-29       Impact factor: 11.025

2.  The trans-SNARE-regulating function of Munc18-1 is essential to synaptic exocytosis.

Authors:  Chong Shen; Shailendra S Rathore; Haijia Yu; Daniel R Gulbranson; Rui Hua; Chen Zhang; Nathan E Schoppa; Jingshi Shen
Journal:  Nat Commun       Date:  2015-11-17       Impact factor: 14.919

3.  Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A.

Authors:  Ian M Campbell; Svetlana A Yatsenko; Patricia Hixson; Tyler Reimschisel; Matthew Thomas; William Wilson; Usha Dayal; James W Wheless; Amy Crunk; Cynthia Curry; Nicole Parkinson; Leona Fishman; James J Riviello; Malgorzata J M Nowaczyk; Susan Zeesman; Jill A Rosenfeld; Bassem A Bejjani; Lisa G Shaffer; Sau Wai Cheung; James R Lupski; Pawel Stankiewicz; Fernando Scaglia
Journal:  Genet Med       Date:  2012-06-21       Impact factor: 8.822

Review 4.  Emerging role of the KCNT1 Slack channel in intellectual disability.

Authors:  Grace E Kim; Leonard K Kaczmarek
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

5.  Genomic Context Analysis of de Novo STXBP1 Mutations Identifies Evidence of Splice Site DNA-Motif Associated Hotspots.

Authors:  Mohammed Uddin; Marc Woodbury-Smith; Ada J S Chan; Ammar Albanna; Berge Minassian; Cyrus Boelman; Stephen W Scherer
Journal:  G3 (Bethesda)       Date:  2018-03-28       Impact factor: 3.154

6.  The Efficacy of Ketogenic Diet for Specific Genetic Mutation in Developmental and Epileptic Encephalopathy.

Authors:  Ara Ko; Da E Jung; Se H Kim; Hoon-Chul Kang; Joon S Lee; Seung T Lee; Jong R Choi; Heung D Kim
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

7.  Confirming the contribution and genetic spectrum of de novo mutation in infantile spasms: Evidence from a Chinese cohort.

Authors:  Liying Liu; Fang Liu; Qiuhong Wang; Hua Xie; Zhengchang Li; Qian Lu; Yangyang Wang; Mengna Zhang; Yu Zhang; Jonathan Picker; Xiaodai Cui; Liping Zou; Xiaoli Chen
Journal:  Mol Genet Genomic Med       Date:  2021-05-05       Impact factor: 2.183

8.  Syntaxin binding protein 1 is not required for allergic inflammation via IgE-mediated mast cell activation.

Authors:  Zhengli Wu; Adam J MacNeil; Jason N Berman; Tong-Jun Lin
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

9.  Mosaicism and incomplete penetrance of PCDH19 mutations.

Authors:  Aijie Liu; Xiaoxu Yang; Xiaoling Yang; Qixi Wu; Jing Zhang; Dan Sun; Zhixian Yang; Yuwu Jiang; Xiru Wu; Liping Wei; Yuehua Zhang
Journal:  J Med Genet       Date:  2018-10-04       Impact factor: 6.318

Review 10.  Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.

Authors:  Shunli Liu; Liyuan Wang; Xiao Tang Cai; Hui Zhou; Dan Yu; Zhiling Wang
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.